J. Dufer et al., NUCLEAR-DNA CONTENT AND CHROMATIN TEXTURE IN MULTIDRUG-RESISTANT HUMAN LEUKEMIC-CELL LINES, International journal of cancer, 60(1), 1995, pp. 108-114
Nuclear morphological alterations associated with multidrug resistance
(MDR) were evaluated by image cytometry in various human leukemic cel
l sub-lines: 3 cell lines with P-gp-mediated resistance (CEM-VLB, HL60
/Vinc, K562-Dox), the non-Pgp-mediated MDR HL60/AR leukemic cell line
with over-expression of MRP, and the at-MDR CEM-VM I leukemic cell lin
e with alteration of topoisomerase II. All these MDR cell sob-lines we
re obtained by drug selection and were compared with their sensitive c
ounterparts and with the hamster LR73-R cell line obtained by transfec
tion of mouse mdr 1 cDNA. All MDR cell sub-lines obtained by drug sele
ction displayed decreased DNA Feulgen stainability as compared with th
eir respective sensitive parental cell line, a phenomenon not observed
in the transfected LR73-R cells. Nuclear texture analysis on G(0)/G(1
)-selected cell nuclei revealed 2 types of textural phenotype. The fir
st phenotype was characterized by chromatin decondensation with small
but compact chromatin clumps, and was observed in drug-selected P-gp-m
ediated MDR cells (CEM-VLB, HL6O-Vinc, K562-Dox) and in the non-P-gp-m
ediated MDR HL60/AR cell line. The second phenotype was characterized
by a condensed and homogeneous chromatin pattern, and was observed in
the at-MDR CEM-VM I cell line. LR73-R cells transfected with mdr 1 cDN
A did not display any significant changes in textural phenotype as com
pared with sensitive LR73 cells, suggesting that P-gp over-expression
alone cannot account for the cytological modifications observed in MDR
cells. These data suggest that multidrug resistance could be associat
ed with specific nuclear morphological changes which appeared to be a
consequence of alterations occurring during selection by cytotoxic dru
gs rather than of P-gp over-expression. (C) 1995 Wiley-Liss, Inc.